Digital Health Investment Weekly Report (Issue 173) Files for IPO

Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!

01 Global Digital Health Investment and Financing Overview

Healthcare Services Provider AbsoluteCare Secures $135 Million in Equity Financing

On July 22, healthcare service provider AbsoluteCare secured $135 million in equity financing from investors including Kinderhook Industries, CVS Health Ventures, Pacific Life, and Lexington Partners. The funds will enhance AbsoluteCare's ability to optimize operations, expand into new markets, and serve new member groups.

BrioHealth Solutions Secures Over $100 Million in Strategic Financing for Artificial Heart Development

On July 21, BrioHealth Solutions, a developer of artificial hearts, secured over $100 million in strategic financing led by Beijing Mentougou Zhuxin Fund, Gao Rong Venture Capital, and Gao Ke Xinjun, with follow-on investments from Sequoia China, Huachuang Capital, and others. This round of financing will be used to accelerate international expansion, continuously drive product technology innovation and pipeline development, and enhance the commercial system within China.

Numan, a Men's Digital Health Guidance Platform, Secures $60 Million in Financing

On July 18, Numan, a digital health guidance platform for men, secured $60 million in funding led by HSBC Innovation Banking UK, with participation from Big Pi Ventures, Endeavor Catalyst, and others. The funds will be used to expand the platform's infrastructure to serve its growing patient base, increase marketing efforts, advance its artificial intelligence capabilities, and support Numan’s growth, including expansion into women's health and deepening patient relationships.

Dental Care Products Manufacturer vVARDIS Secures $50 Million in Financing

On July 18, dental care product manufacturer vVARDIS secured $50 million in funding from healthcare venture capital firm OrbiMed. The funds will be used to refinance existing facilities and support the company’s growth plans for innovative dental products under the Curodont™ brand, as well as its global commercial expansion and vVARDIS’ groundbreaking drill-free treatment technology for early-stage caries.

Shoulder Innovations, a developer of shoulder replacement systems, secures $40 million in convertible note financing

On July 21, Shoulder Innovations, a developer of shoulder replacement systems, secured $40 million in convertible note financing provided by new investor Fidelity Management & Research Company. The proceeds will primarily support the ongoing commercialization of Shoulder Innovations' anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA) implant systems, as well as fund new product development.

Fortuna Health, a developer of medical evaluation platforms, secures $18 million in Series A funding

On July 22, Fortuna Health, a developer of medical evaluation platforms, secured $18 million in Series A funding led by Andreessen Horowitz, with participation from Y Combinator and founders and executives from Abridge, DoorDash, Hex, One Medical, Oscar Health, Scale, and Vanta. The funds will be used to accelerate the company's investment in AI-driven workflows, drive expansion into new states, and help scale infrastructure.

Respiree, a developer of respiratory and cardiac sensors, secures $11.6 million in Series A funding

On July 23, Respiree, a developer of respiratory and cardiac sensors, secured $11.6 million in Series A funding, led by We Venture Capital and ClavystBio, with participation from Adaptive Capital Partners. The funds will be used to support the expansion of Respiree's commercial team and the development of its U.S. operations, as well as to seek FDA approval for its flagship artificial intelligence model and integrate it into its platform, 1Bio.

Clinical Bioanalysis Platform Developer Dash Bio Secures $11 Million in Financing

On July 23, clinical bioanalytical platform developer Dash Bio secured $11 million in financing, led by The Aligned Fund with participation from Freestyle Capital, Cybernetix Ventures, and others. Dash Bio's platform adopts a technology-first approach to develop key services throughout the entire drug development lifecycle, aiming to build new capabilities that leverage artificial intelligence, robotics, and fully integrated software to meet regulatory standards.

Portable Scalp Cooling System Developer Cooler Heads Secures $11 Million in Series A Funding

On July 22, Cooler Heads, a developer of portable scalp cooling systems, secured $11 million in Series A funding, led by Mutual. Capital Partners led the investment, with participation from SHD Partners, Crescent Ridge VC, Cal Innovation Fund, and others. This round of financing will be used to increase manufacturing capacity, expand the commercial team, and develop the next generation of products.

AI Health Platform Everlab Secures $10 Million in Seed Funding

On July 22, artificial intelligence health platform Everlab secured $10 million in seed funding, led by Left Lane Capital. The funds will be used to accelerate Everlab's international expansion, advance the development of its proprietary artificial intelligence health technology platform, and support the launch of a deeply integrated product ecosystem aimed at providing lifelong, proactive care services.

BrioHealth Solutions Collaborates with BioMap to Empower High-Throughput Single-Cell Screening with AI

On July 17, life science instrument manufacturer ZG Bio and AI-driven life sciences R&D company BioMap entered into a strategic partnership aimed at accelerating the development of innovative antibody therapies. This collaboration will deeply integrate ZG Bio's OptoBot® series high-throughput cell screening platform with BioMap’s AI technology to jointly establish an intelligent R&D system covering the entire drug discovery process.

BrioHealth Solutions Collaborates with ShenQi Medical to Build a Full-Cycle Heart Failure Treatment Solution

On July 18, BrioHealth Solutions, an artificial heart developer, and ShenQi Medical, a cardiovascular interventional device developer, reached a strategic cooperation at the 10th China Heart Failure Conference. The two parties will integrate their respective advantageous resources to promote the upgrading of advanced heart failure diagnosis and treatment service systems through a product portfolio of "artificial heart + ultrafiltration technology," building solutions covering early intervention to end-stage support, providing heart failure patients with more comprehensive and precise treatment options.

Ark Health collaborates with Novo Nordisk to build a new ecosystem for chronic disease health management

On July 18, Ark Jianke and Novo Nordisk reached a cooperation agreement at the 3rd China International Chain Expo. They will jointly launch project collaborations focusing on the management of serious chronic diseases such as diabetes and obesity. Relying on its AI application service scenarios and convenient pharmaceutical services, Ark Jianke will combine Novo Nordisk’s professional expertise and innovative products in the field of diabetes and obesity treatment to build a full-cycle health management service loop covering medication guidance, medication reminders, effect tracking, and health education.

Healthcare Solutions Provider Knipper Health Acquires eBlu Solutions

On July 21, healthcare solutions provider Knipper Health acquired eBlu Solutions, a company focused on delivering automated platforms designed to streamline complex administrative tasks associated with specialty therapies. This acquisition combines eBlu's automated platform with Knipper Health's extensive distribution network, aiming to simplify benefit verification, prior authorization, and patient onboarding processes for specialty providers.

DeepHealth, a wholly-owned subsidiary of RadNet, acquires iCAD

On July 17, DeepHealth, a wholly-owned subsidiary of outpatient imaging services provider RadNet, acquired iCAD, an AI-driven breast health solutions provider. This acquisition integrates iCAD's commercial, technical, and regulatory capabilities into DeepHealth, advancing its use of artificial intelligence and imaging technology to address clinical and operational challenges in screening and diagnosis. It also extends its reach to over 10 million mammograms annually, accelerating the application of AI and screening compliance.

ArteryNet/Arterial Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/Fierce Health, etc.

Compiled by: Hou Zhancái, Huáng Chāngjiàn‍‍‍

Share

Like

Tap to view